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Background: Beauveria bassiana is an entomopathogenic fungus and is a rare cause of keratitis. We present a
case of fungal keratitis caused by B. bassiana that was diagnosed by in vivo confocal microscopy and in vitro
corneal cultures. In addition, we determined the temperature- and drug-sensitivities of the isolated strain of
B. bassiana.
Case presentation: A 59-year-old Japanese man with a 2-month history of keratitis was examined by slit-lamp
biomicroscopy, in vivo confocal microscopy, and histology and cultures of corneal scrapings. The corneal
scrapings were used to determine the minimal inhibitory concentrations of different antifungal drugs and also
to determine the temperature-sensitivity. In vivo confocal microscopy and histological examinations showed
filamentous fungal keratitis. The characteristics of the fungal growth indicated that the keratitis was caused by
B. bassiana. The keratitis responded poorly to systemic and topical voriconazole and to natamycin ointment.
However, it was resolved after changing the natamycin to micafungin combined with surgical debridement.
The isolated strain was sensitive to itraconazole, miconazole, micafungin, voriconazole, and resistant to flucytosine and
fluconazole. It was moderately sensitive to amphotericin B, and natamycin. After 7 days in culture, the isolate grew small
white colonies at 25°C, very small colonies at 35°C and 37°C.
Conclusion: The drug-sensitivity and temperature-sensitivity profiles of B. bassiana should be helpful in the
treatment of B. bassiana keratitis. Therapeutic surgery may be helpful for mycotic keratitis poorly responsive to
medical therapy alone.
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sensitivity growthBackground
Beauveria bassiana is a fungus that is distributed world-
wide. It can be isolated from soil, insects, and mites.
It is an entomopathogenic fungi and is used as a bio-
logical control agent for insect pests as alternative
supplements to chemical insecticides [1-3]. Although
B. bassiana is considered to be non-pathogenic to verte-
brates, a small number of patients with keratitis caused* Correspondence: shiraia@m.ehime-u.ac.jp
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unless otherwise stated.by B. bassiana have been reported [4-13]. We present
a case of fungal keratitis caused by B. bassiana that
was diagnosed by in vivo confocal microscopy and
in vitro corneal cultures. In addition, we determined
the temperature- and drug-sensitivities of the isolated
strain of B. bassiana.Case presentation
The patient was a 59-year-old Japanese man who noted
a corneal opacity in his right eye in October, 2009.
However, he did not seek treatment for the opacity for
about two months. He visited a private ophthalmo-
logical clinic on December 11, 2009, because his righttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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patient was a farm worker, but did not use entomo-
pathogenic fungi as a biological control agent. He had
no systemic diseases and no signs or symptoms of im-
munosuppression during the clinical course. He was di-
agnosed with infectious keratitis and was treated with
topical gatifloxacin and erythromycin eye ointment for
two weeks. Because the signs and symptoms did not
improve, he was referred to the Ehime University Hospital
on December 28, 2009.
On the initial examination, his best-corrected visual
acuity was 20/500 OD and 20/16 OS. Slit-lamp examin-
ation of the right eye showed a grayish stromal infiltrate
with a dry texture and indistinct margins (Figure 1A).
Examination of the cornea with in vivo confocal micros-
copy (HRT II-RCM; Heidelberg Engineering, Heidelberg,
Germany) showed a mass of branching and interlocking
white lines in the area of the infiltrate suggesting fila-
mentous fungus keratitis (Figure 2A). Microscopic
examination of corneal scrapings showed filamentous
fungal hyphal fragments (Figure 2B).
Treatment was begun with oral voriconazole (400 mg/day)
p.o., topical 0.1% voriconazole hourly, and natamycin
eye ointment 5 times/day. Because the lesion did not
respond despite the intensive antifungal therapy, the
isolate from the corneal scrapings was sent to the First
Laboratory in Medical Mycology Research Center, Chiba
University for identification and to determine the min-
imal inhibitory concentrations (MICs) to different anti-
fungal drugs (Table 1).
The corneal scrapings grew fungal colonies on Sabouraud
dextrose agar and white colonies on potato dextrose
agar (Figure 3A). Microscopic examination of the
culture media stained with lactophenol cotton blue
showed conidia in distinctive blue spore balls com-
posed of a cluster of conidiogenous cells. The conidio-
genous cells were short and ovoid and terminated in a
narrow apical extension or rachis. The rachis was elon-
gated after each conidium resulting in a long zig-zagFigure 1 Slit-lamp photographs of the clinical course of Beauveria bas
showing a grayish stromal infiltrate with a dry texture and indistinct ma
no improvement in the grayish stromal infiltrate. C. Slit-lamp photograp
the stroma.extension. These features are characteristic of B. bassiana
(Figure 3B).
The isolate was confirmed to be B. bassiana by DNA
sequencing at the First Laboratory in Medical Mycology
Research Center, Chiba University. The MIC of natamy-
cin was determined to be 1 μg/ml by the modified agar
plate dilution method at the Department of Infection
Control, Osaka University Hospital [14-16].
After receiving the MIC results, the natamycin eye
ointment (5 times/day) was changed to topical 0.1%
micafungin (hourly) along with topical 0.1% voricona-
zole. During the next 3 months, surgical debridement
was also performed 3 times and the infectious lesion
slowly improved. Finally, the infectious lesion healed but
with mild scar formation (Figure 1C). His best-corrected
visual acuity in his right eye improved to only 20/100
because of the corneal opacity and irregular astigmatism
due to the surgical debridement.
To try to determine the cause of the slow clinical
course and poor response to antifungal agents, the iso-
late was grown on Sabouraud dextrose agar at 25°C, 35°C,
and 37°C for up to 7 days at the Clinical Laboratory of
Ehime University Hospital as described in detail [14].
The isolate grew very slowly, and no determination
could be made at 5 days when most filamentous fungi
would have already grown colonies. At 7 days, the isolate
grew small white colonies at 25°C, and very small col-
onies at 35°C and 37°C (Figure 4).
Discussion
The entomopathogenic fungi belonging to the genus
Beauveria are rare pathogens in humans, and only 11
cases of keratitis due to Beauveria species have been re-
ported [4-13]. Because of the limited number of cases,
the clinical features of B. bassiana keratitis have not
been determined. The course of our non-necrotic keratitis
case was slow-growing, there was no clinical improvement
after treatment with voriconazole even though vorico-
nazole was the preferable antibiotic according to thesiana keratitis. A. Slit-lamp photograph taken at the initial examination
rgins. B. Slit-lamp photograph 1 month after antifungal therapy with
h 10 month after treatment showing a scar with no infiltration into
Figure 2 In vivo confocal microscopic image of Beauveria bassiana keratitis. A. A mass of interlocking and branching white lines in
the area of the infiltrate indicating filamentous fungi. B. Microscopic examination of the corneal scrapings showing filamentous fungal
hyphal fragments.
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Low et al., Kisla et al., and Tu et al., were also slow-
growing with late penetration into the corneal stroma
which is consistent with our case [6,7,12]. In addition,
the resistance to antifungal therapy was also consist-
ent with our case [6-8,12].
Our antifungal susceptibility tests showed that the iso-
lated strain was sensitive to micafungin and voriconazole
and moderately sensitive to natamycin. There have been
several reports on the drug sensitivity of B. bassiana.
Tu et al. and Figueira et al. reported that both of their
strains were sensitive to posaconazole and voriconazole
but resistant to amphotericin. These sensitivities are
similar to that of our strain of B. bassiana [5,12]. The re-
sults of Sonoyama et al. showed that the drug sensitivity
of their Beauveria species was similar to our strain [11].
In addition, voriconazole was ineffective in both cases.
Otherwise, the clinical course of the two cases was veryTable 1 Minimal inhibitory concentrations of different
antifungal drugs









RPMI; Roswell Park Memorial Institute medium, YNB; yeast nitrogen base.
AMPH; amphotericin B, 5-FC; flucytosine, FLCZ; fluconazole, ITZ; itraconazole,
MCZ; miconazole, MCFG; micafungin, VCZ; voriconazole, MIC; minimal
inhibitory concentration.similar, viz., slow-growing, non-necrotic keratitis, and
clinically resistant to voriconazole. However, the causa-
tive strain was sensitive to voriconazole. Sonoyama et al.
also had a successful treatment with topical voriconazole,
although they also treated the eye with topical miconazole
and oral itraconazole which their strain was sensitive
to [11].
The results of the temperature sensitivity profile
supported the microbiological results reported by
Figueira et al. [5]. The temperature in the anterior cham-
ber of the eye is generally 35°C or higher, and that of theFigure 3 Microscopic examination of the culture media.
Microscopic examination of the culture media stained with
lactophenol-cotton blue shows conidia in distinctive blue spore balls
composed of clusters of conidiogenous cells. The conidiogenous cells
are short and ovoid and terminate in a narrow apical extension called
a rachis. The rachis elongates after each conidium is produced resulting
in a long zig-zag extension. These features are characteristic of
B. bassiana.
Figure 4 Fungal colonies grown on Sabouraud dextrose agar at different temperatures. The isolate grew small white colony at 25°C, very
small colony at 35°C, and 37°C after 7 days. (n = 3).
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temperature [17,18]. Thus, we suggest that the B. bassiana
strain in our case could not grow at temperatures of 35°C
or higher and thus did not penetrate into the corneal
stroma. This temperature sensitivity might be one reason
why B. bassiana is a rare pathogen in humans, and why
the infections in humans are limited to the body surface
such as the cornea.
Another reason for the infection of the cornea may
be the ability of B. bassiana to produce chitinase
which lyses not only chitin but also keratin and colla-
gen. This would then enable it to adhere and penetrate
the cornea [5,12]. B. bassiana has 3 different cell
forms and can adhere to both hydrophobic and hydro-
philic surfaces. This would enhance its adherence to
the corneal surface along with the permissive avascular
immune environment of the central cornea [5,12]. In
addition, the slow-growing property may be one of the
reasons why the initial intensive antifungal therapy
seemed to be clinically ineffective, because voricona-
zole works by preventing fungi from producing ergos-
terol which is a component of fungal cell membranes,
and ergosterol is necessary for fungi to proliferate.
Thus, the initial treatment with voriconazole only ap-
peared to be ineffective in such slow-growing fungi.
Although the clinical course was very slow, the infec-
tious lesion improved after changing the treatment from
natamycin eye ointment to topical micafungin and surgical
debridement.
Micafungin is a echinocandins which blocks fungal cell
wall beta-glucan synthesis, thus the different actions of
voriconazole and micafungin may have a synergetic ef-
fect. It is also possible that the surgical debridement
might have worked in our case because it removed anti-
genic and infectious elements and necrotic tissues. This
supports the results of earlier studies that surgical de-
bridement or keratectomy is required for mycotic kera-
titis that respond poorly to medical therapy [19,20].
Further experiments on animals may be helpful in testing
this hypothesis.Conclusions
We report a case of B. bassiana keratitis. The drug-
sensitivity and temperature sensitivity profiles of B. bassiana
should be helpful in diagnosing and treating B. bassiana
keratitis. Therapeutic surgery may also be helpful for
mycotic keratitis poorly responsive to medical therapy.Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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